Neochromosome Announces Collaboration with University of Edinburgh Creating Defined Variant Libraries for Designer Enzymes
Creating improved engineering processes for designer enzymes could lead to safer and more effective therapeutics, such as enzyme replacement therapy, for a broad range of genetic diseases.
- Creating improved engineering processes for designer enzymes could lead to safer and more effective therapeutics, such as enzyme replacement therapy, for a broad range of genetic diseases.
- To overcome this challenge, scientists use computational and experimental techniques to create libraries of thousands of ‘designer’ synthetically created enzymes.
- Therefore, there is an urgent need to establish new methods of reliably creating designer enzymes on demand,” said Dr. Leslie Mitchell, Co-founder and CEO of Neochromosome.
- From defined variant libraries and variant mining to clonal selection and DNA repository, Neochromosome works with its partners through an iterative, customized process to ensure high-quality deliverables with fast turnaround times.